These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma. Li M; Shi K; Tang X; Wei J; Cun X; Chen X; Yu Q; Zhang Z; He Q Eur J Pharm Sci; 2018 Nov; 124():240-248. PubMed ID: 30071282 [TBL] [Abstract][Full Text] [Related]
25. Multifunctional Targeting Liposomes of Epirubicin Plus Resveratrol Improved Therapeutic Effect on Brain Gliomas. Kong D; Hong W; Yu M; Li Y; Zheng Y; Ying X Int J Nanomedicine; 2022; 17():1087-1110. PubMed ID: 35313461 [TBL] [Abstract][Full Text] [Related]
26. Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties. Dos Santos Rodrigues B; Lakkadwala S; Kanekiyo T; Singh J Int J Nanomedicine; 2019; 14():6497-6517. PubMed ID: 31616141 [TBL] [Abstract][Full Text] [Related]
27. In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin. Ashrafzadeh MS; Akbarzadeh A; Heydarinasab A; Ardjmand M Int J Nanomedicine; 2020; 15():7035-7049. PubMed ID: 33061366 [TBL] [Abstract][Full Text] [Related]
28. Preparation and evaluation of Baicalin-loaded cationic solid lipid nanoparticles conjugated with OX26 for improved delivery across the BBB. Liu Z; Zhao H; Shu L; Zhang Y; Okeke C; Zhang L; Li J; Li N Drug Dev Ind Pharm; 2015 Mar; 41(3):353-61. PubMed ID: 25784073 [TBL] [Abstract][Full Text] [Related]
29. Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB. Chen C; Duan Z; Yuan Y; Li R; Pang L; Liang J; Xu X; Wang J ACS Appl Mater Interfaces; 2017 Feb; 9(7):5864-5873. PubMed ID: 28128553 [TBL] [Abstract][Full Text] [Related]
30. A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration. Xu X; Li J; Han S; Tao C; Fang L; Sun Y; Zhu J; Liang Z; Li F Eur J Pharm Sci; 2016 Jun; 88():178-90. PubMed ID: 26965003 [TBL] [Abstract][Full Text] [Related]
31. A Dual Receptor Targeting- and BBB Penetrating- Peptide Functionalized Polyethyleneimine Nanocomplex for Secretory Endostatin Gene Delivery to Malignant Glioma. Lu L; Chen H; Wang L; Zhao L; Cheng Y; Wang A; Wang F; Zhang X Int J Nanomedicine; 2020; 15():8875-8892. PubMed ID: 33209022 [TBL] [Abstract][Full Text] [Related]
32. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands. Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462 [TBL] [Abstract][Full Text] [Related]
33. In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats. Zhang Y; Boado RJ; Pardridge WM J Gene Med; 2003 Dec; 5(12):1039-45. PubMed ID: 14661179 [TBL] [Abstract][Full Text] [Related]
34. A Combined Approach Employing Chlorotoxin-Nanovectors and Low Dose Radiation To Reach Infiltrating Tumor Niches in Glioblastoma. Tamborini M; Locatelli E; Rasile M; Monaco I; Rodighiero S; Corradini I; Franchini MC; Passoni L; Matteoli M ACS Nano; 2016 Feb; 10(2):2509-20. PubMed ID: 26745323 [TBL] [Abstract][Full Text] [Related]
35. Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma. Fu S; Liang M; Wang Y; Cui L; Gao C; Chu X; Liu Q; Feng Y; Gong W; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C ACS Appl Mater Interfaces; 2019 Jan; 11(2):1841-1854. PubMed ID: 30582685 [TBL] [Abstract][Full Text] [Related]
36. Asn-Gly-Arg-modified polydopamine-coated nanoparticles for dual-targeting therapy of brain glioma in rats. Hu J; Zhang X; Wen Z; Tan Y; Huang N; Cheng S; Zheng H; Cheng Y Oncotarget; 2016 Nov; 7(45):73681-73696. PubMed ID: 27655664 [TBL] [Abstract][Full Text] [Related]
37. Use of chlorotoxin for targeting of primary brain tumors. Soroceanu L; Gillespie Y; Khazaeli MB; Sontheimer H Cancer Res; 1998 Nov; 58(21):4871-9. PubMed ID: 9809993 [TBL] [Abstract][Full Text] [Related]
38. Characteristics of sequential targeting of brain glioma for transferrin-modified cisplatin liposome. Lv Q; Li LM; Han M; Tang XJ; Yao JN; Ying XY; Li FZ; Gao JQ Int J Pharm; 2013 Feb; 444(1-2):1-9. PubMed ID: 23347891 [TBL] [Abstract][Full Text] [Related]
39. Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals. Zong T; Mei L; Gao H; Cai W; Zhu P; Shi K; Chen J; Wang Y; Gao F; He Q Mol Pharm; 2014 Jul; 11(7):2346-57. PubMed ID: 24893333 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of nanoscaled dual targeting drug-loaded liposomes on inhibiting vasculogenic mimicry channels of brain glioma. Xie HJ; Zhan-Dui N; Zhao J; Er-Bu AGA; Zhen P; ZhuoMa D; Sang T Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):596-605. PubMed ID: 34514904 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]